CHI3L2 and myeloid sarcoma: Inflammatory glycoproteins chitinase-3-like protein 1, and chitinase-3-like protein 2 (YKL-39) have emerged as biomarkers for multiple sclerosis (MS), demyelinating diseases, VM, and acute bacterial meningitis.